Commentary reviews serum amyloid A as a marker of inflammation in rheumatoid arthritis, highlighting links to cardiovascular and renal risk.
the paper by Targoska-Stpniak and Majdan titled "Serum Amyloid A as a Marker of Persistent Inflammation and an Indicator of Cardiovascular and Renal Involvement in Patients with Rheumatoid Arthritis" in which the investigators reported that high serum amyloid A (SAA) concentration was strongly associated with activity of the disease and risk of cardiovascular and renal involvement in patients with rheumatoid arthritis We thank the authors for their detailed report. However, we wish to make some comments on SAA.
No takes yet. Share an insight, caveat, or question.
Ağıllı et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: